Provectus Biopharmaceuticals, Inc. (PVCT)

OTCMKTS · Delayed Price · Currency is USD

0.0865

+0.0014 (1.67%)

Aug 15, 2025, 3:53 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	2016 - 2018
Immunotherapy Medicines	557.71K	Log In	Log In	Log In	Log In	Upgrade
Immunotherapy Medicines Growth	-43.61%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	2016 - 2018
United States	557.71K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-43.61%	Log In	Log In	Log In	Log In	Upgrade